Adalimumab-bwwd
NDC 83457-187, adalimumab-bwwd, solution, from Cordavis Limited.
- Product NDC
- 83457-187
- Status
- Listed
- Labeler
- Cordavis Limited
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761059
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83457-187 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADALIMUMAB40 mg/.4mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83457-187-01 | 83457018701 | 2 SYRINGE in 1 CARTON (83457-187-01) / .4 mL in 1 SYRINGE (83457-187-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c24655e5-796e-4127-b716-92f08d649c83
Use it
Look up 83457-187 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83457-187 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83457-187. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.